Genesystem Co., Ltd. (KOSDAQ:363250)

South Korea · Delayed Price · Currency is KRW

3,985.00

-65.00 (-1.60%)

At close: Oct 23, 2026

Genesystem Financials Overview

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Revenue	1,010	381.36	1,208	897.03	3,653
Revenue Growth	-4.59%	-68.42%	34.64%	-75.44%	-
Gross Profit	-2,008	-2,465	-1,820	-1,586	1,167
Operating Income	-7,852	-9,690	-10,116	-9,484	-6,605
Net Income	-10,282	-11,955	-8,915	-7,915	-8,996
Earnings Per Share	-1418.79	-1754.01	-1302.43	-1139.05	-1303.50
EPS Growth	-	-	-	-	-

Revenue by Geography

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
South Korea	675.42	207.75	199.04	245.12	693
Asia	273.02	133.56	940.68	466.77	1,682
Europe	51.35	39.3	46.71	184.04	1,229
North America	-	0.75	0.66	1.11	0.98
Africa	-	-	20.67	-	47.46
Total	999.79	381.36	1,208	897.03	3,653

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Cash & Investments	4,820	1,874	7,694	14,348	26,489
Total Debt	3,887	4,045	4,121	4,488	4,095
Net Cash (Debt)	932.7	-2,172	3,574	9,860	22,394
Net Cash Growth	568.83%	-	-63.75%	-55.97%	-
Net Cash Per Share	128.70	-318.62	522.08	1418.86	3244.73

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Operating Cash Flow	-8,284	-6,883	-7,337	-7,812	-6,417
Capital Expenditures	-521.75	-219.66	-258.73	-362.85	-238.43
Free Cash Flow	-8,806	-7,103	-7,595	-8,174	-6,655
Free Cash Flow Growth	-	-	-	-	-

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Gross Margin	-198.81%	-	-150.69%	-176.81%	31.96%
Operating Margin	-777.39%	-2541.03%	-837.58%	-1057.33%	-180.80%
Pretax Margin	-1375.23%	-4172.23%	-801.44%	-882.09%	-193.26%
Profit Margin	-1017.98%	-3134.97%	-738.17%	-882.41%	-246.26%
FCF Margin	-871.87%	-1862.60%	-628.89%	-911.27%	-182.18%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Oct '26 Oct 24, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Forward PE	-	14.85	14.85	14.85	-
PS Ratio	32.69	73.33	49.15	72.65	15.88